EUVIMEDEUVIMED entdecken
Crossref

Dual-targeting fluorous peptide proteolysis-targeting chimeras for cancer therapy

Guangyu Rong, Yuhan Li, Fang Zhu, Yiteng Lu, Zhengwang Sun, Jiaxu Hong, Yiyun Cheng

Journal of Controlled Release · 2026-03 · 391 · 114591

DOI: 10.1016/j.jconrel.2025.114591 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Controlled Release, 2026-03. Verfasst von Guangyu Rong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Eye & ENT Hospital, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science, Fudan …. Hauptthemen laut MEDLINE: Peptides, bcl-X Protein, Melanoma, Experimental, B7-H1 Antigen. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 62 Literaturangaben. Gefördert von: Shanghai Rising-Star Program, National Science Fund for Distinguished Young Scholars, East China Normal University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolysis-targeting chimeras (PROTACs) offer a powerful strategy for degrading disease-causing proteins. Simultaneous degradation of two oncogenic proteins by PROTACs can yield synergistic therapeutic effects. Here, we developed a dual-targeting fluorous peptide-based PROTAC (DFP-PROTAC) that leverages supramolecular self-assembly for cancer therapy. By conjugating PD-L1- and Bcl-xL-binding peptides to fluorous tags, we generated carrier-free nanoparticles that enter cells via macropinocytosis and achieve efficient endosomal escape, mediating simultaneous degradation of both extracellular PD-L1 and cytosolic Bcl-xL through the ubiquitin-proteasome system. Our results demonstrate that DFP-PROTAC coordinately restores antitumor immunity and apoptotic sensitivity while achieving superior antitumor efficacy with excellent biocompatibility in B16-F10 melanoma-bearing mice, highlighting its therapeutic potential for cancer treatment. This modular fluorous platform offers a versatile strategy for degrading multiple protein targets in the treatment of various diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peptidesbcl-X ProteinMelanoma, ExperimentalB7-H1 AntigenAntineoplastic AgentsAnimalsProteolysisHumansMice, Inbred C57BLCell Line, TumorMiceFemaleNanoparticlesApoptosis

Stichwörter der Autor:innen

Co-assemblyFluorous peptidesIntracellular peptide deliveryPROTACTumor therapy

Substanzen

Peptidesbcl-X ProteinB7-H1 AntigenAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Ophthalmology, Eye & ENT Hospital, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200031, China.
  • Shanghai Frontiers Science Center of Genome Editing and Cell Therapy, Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, East China Normal University, Shanghai 200241, China.
  • Department of Musculoskeletal Oncology, Fudan University, Shanghai Cancer Center, Shanghai 200032, China. Electronic address: specialsamsun@126.com.
  • Department of Ophthalmology, Eye & ENT Hospital, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200031, China; National Health Commission of Myop…
  • Department of Ophthalmology, Eye & ENT Hospital, State Key Laboratory of Brain Function and Disorders, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200031, China; Shanghai Frontiers Science Center…

Förderung

  • Shanghai Rising-Star Program
  • National Science Fund for Distinguished Young Scholars
  • East China Normal University
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Shanghai Health and Medical Development Foundation

Zitieren

APA

Rong, G., Li, Y., Zhu, F., Lu, Y., Sun, Z., Hong, J., & Cheng, Y. (2026). Dual-targeting fluorous peptide proteolysis-targeting chimeras for cancer therapy. Journal of Controlled Release, 391, 114591. https://doi.org/10.1016/j.jconrel.2025.114591

Vancouver

Rong G, Li Y, Zhu F, Lu Y, Sun Z, Hong J, et al. Dual-targeting fluorous peptide proteolysis-targeting chimeras for cancer therapy. Journal of Controlled Release. 2026;391:114591. doi:10.1016/j.jconrel.2025.114591

BibTeX
@article{Rong2026,
  author = {Rong, Guangyu and Li, Yuhan and Zhu, Fang and Lu, Yiteng and Sun, Zhengwang and Hong, Jiaxu and Cheng, Yiyun},
  title = {Dual-targeting fluorous peptide proteolysis-targeting chimeras for cancer therapy},
  journal = {Journal of Controlled Release},
  year = {2026},
  volume = {391},
  pages = {114591},
  doi = {10.1016/j.jconrel.2025.114591}
}
Kostenlos starten →